High plasma adiponectin concentration is associated with all-cause mortality in patients with carotid atherosclerosis

Atherosclerosis

Volumn 225, Issue 2, 2012, Pages 491-496

  Persson, Jonas ^a,b   Folkersen, Lasse ^b   Ekstrand, Johan ^c   Helleberg, Johan ^b   Gabrielsen, Anders ^b   Lundman, Pia ^a   Hedin, Ulf ^c   Paulsson Berne, Gabrielle ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adiponectin; Atherosclerosis; Carotid endarterectomy; Mortality; Risk factor

Indexed keywords

ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 6; ORAL ANTIDIABETIC AGENT;

AGED; ALL CAUSE MORTALITY; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CONCENTRATION (PARAMETERS); FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CAROTID STENOSIS; COMORBIDITY; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84869501719     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.036     Document Type: Article

References (36)

1. Satoh H., Nguyen M.T., Trujillo M., et al. Adenovirus-mediated adiponectin expression augments skeletal muscle insulin sensitivity in male Wistar rats. Diabetes 2005, 54(5):1304-1313.
2. Yamauchi T., Kamon J., Minokoshi Y., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8(11):1288-1295.
3. Kubota N., Yano W., Kubota T., et al. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 2007, 6(1):55-68.
4. Okamoto Y., Kihara S., Ouchi N., et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002, 106(22):2767-2770.
5. Motoshima H., Wu X., Mahadev K., Goldstein B.J. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun 2004, 315(2):264-271.
6. Kobayashi H., Ouchi N., Kihara S., et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004, 94(4):e27-31.
7. Yokota T., Oritani K., Takahashi I., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000, 96(5):1723-1732.
8. Wulster-Radcliffe M.C., Ajuwon K.M., Wang J., Christian J.A., Spurlock M.E. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 2004, 316(3):924-929.
9. Ouedraogo R., Gong Y., Berzins B., et al. Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest 2007, 117(6):1718-1726.
10. Gonon A.T., Widegren U., Bulhak A., et al. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide. Cardiovasc Res 2008, 78(1):116-122.
11. Pilz S., Horejsi R., Moller R., et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 2005, 90(8):4792-4796.
12. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23(1):85-89.
13. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. J Am Med Assoc 2004, 291(14):1730-1737.
14. Persson J., Lindberg K., Gustafsson T.P., Eriksson P., Paulsson-Berne G., Lundman P. Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. J Intern Med 2010, 268(2):194-205.
15. Matsumoto M., Ishikawa S., Kajii E. Association of adiponectin with cerebrovascular disease: a nested case-control study. Stroke 2008, 39(2):323-328.
16. Stott D.J., Welsh P., Rumley A., et al. Adipocytokines and risk of stroke in older people: a nested case-control study. Int J Epidemiol 2009, 38(1):253-261.
17. Pilz S., Mangge H., Wellnitz B., et al. Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab 2006, 91(11):4277-4286.
18. Dekker J.M., Funahashi T., Nijpels G., et al. Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 2008, 93(4):1489-1496.
19. Agardh H.E., Folkersen L., Ekstrand J., et al. Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis. J Intern Med 2011, 269(2):200-210.
20. Hammar N., Alfredsson L., Rosen M., Spetz C.L., Kahan T., Ysberg A.S. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 2001, 30(Suppl. 1):S30-S34.
21. Public comparisons of quality and efficacy of medical service - comparisons between county councils 2009, The National Board of Health and Welfare.
22. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130(6):461-470.
23. Urbina E.M., Khoury P., Martin L.J., D'Alessio D., Dolan L.M. Gender differences in the relationships among obesity, adiponectin and brachial artery distensibility in adolescents and young adults. Int J Obes (Lond) 2009, 33(10):1118-1125.
24. Cavusoglu E., Ruwende C., Chopra V., et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006, 27(19):2300-2309.
25. Beatty A.L., Zhang M.H., Ku I.A., Na B., Schiller N.B., Whooley M.A. Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study. Atherosclerosis 2012, 220(2):587-592.
26. Kistorp C., Faber J., Galatius S., et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005, 112(12):1756-1762.
27. Walkey A.J., Rice T.W., Konter J., et al. Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure. Crit Care Med 2010, 38(12):2329-2334.
28. Efstathiou S.P., Tsioulos D.I., Tsiakou A.G., Gratsias Y.E., Pefanis A.V., Mountokalakis T.D. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 2005, 36(9):1915-1919.
29. Ogorodnikova A.D., Wassertheil-Smoller S., Mancuso P., et al. High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study. Stroke 2010, 41(7):1376-1381.
30. Whiteley W., Jackson C., Lewis S., et al. Association of circulating inflammatory markers with recurrent vascular events after stroke: a Prospective Cohort Study. Stroke 2011, 42(1):10-16.
31. Vemmos K., Ntaios G., Spengos K., et al. Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox. Stroke 2011, 42(1):30-36.
32. van Lammeren G.W., Moll F.L., Blankestijn P.J., et al. Decreased kidney function: an unrecognized and often untreated risk factor for secondary cardiovascular events after carotid surgery. Stroke 2011, 42(2):307-312.
33. Zhu W., Cheng K.K., Vanhoutte P.M., Lam K.S., Xu A. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 2008, 114(5):361-374.
34. Lombardo A., Biasucci L.M., Lanza G.A., et al. Inflammation as a possible link between coronary and carotid plaque instability. Circulation 2004, 109(25):3158-3163.
35. Barseghian A., Gawande D., Bajaj M. Adiponectin and vulnerable atherosclerotic plaques. J Am Coll Cardiol 2011, 57(7):761-770.
36. Ogata J., Yamanishi H., Ishibashi-Ueda H. Review: role of cerebral vessels in ischaemic injury of the brain. Neuropathol Appl Neurobiol 2011, 37(1):40-55.